Cancer

Multiple sclerosis, lung cancer, and 50 marathons: Aaron Hawkins about to reach amazing milestone

“He has been a blessing and role model for so many,” his doctor Jonathan Nesbitt says.

Molecular testing across tumor types

The KRAS inhibitor sotorasib is newly approved for one kind of lung cancer; Vanderbilt researchers ask if it should be considered for another type if the tumor has the gene mutation it targets.

Biltibo receives career development award to support hematology research

Vanderbilt’s Eden Biltibo, MD, a clinical fellow in the Division of Hematology and Oncology, has been selected for the 2022 ASH-CIBMTR-ASTCT Career Development Award.

Computer eyeballs graft-vs-host disease

A machine learning algorithm identified areas of skin affected by chronic graft-versus-host disease on par with clinicians, opening the door to streamlining and standardizing this measure of patient response to therapy.

By Paul Govern

April 7, 2022

New prognosis predictor and target for gastric cancer

The protein CGA — a subunit of glycoprotein hormones — is a biomarker that predicts chemoresistance in gastric cancer and could be targeted along with EGFR to restore chemosensitivity.

By Sarah E. Glass

Inga Saknite, PhD, Eric Tkaczyk, MD, PhD, and colleagues are studying how white blood cell motion in the skin’s microvasculature can help predict which stem cell and bone marrow transplant patients would have a relapse of their blood cancer. (photo by Anne Rayner)

March 28, 2022

Study finds 10-second videos predict blood cancer relapse

Vanderbilt research shows that 10-second videos of white blood cell motion in the skin’s microvasculature greatly improved the prediction of which stem cell and bone marrow transplant patients would have a relapse of their blood cancer.